3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
13
Weight Loss
5
Obesity
5
Overweight
2
Menstruation Disturbances
2
Intermittent Fasting
2
Insulin Resistance
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Motor Activity
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Cancer Female
1
Body Weight
1
Interventions
Clomiphene
18
Metformin
12
Letrozole
11
Triptorelin Pamoate
7
cetrorelix
5
Menotropins
5
Chorionic Gonadotropin
4
Surveys and Questionnaires
3
Sperm Injections, Intracytoplasmic
3
Medroxyprogesterone Acetate
3
Inositol
3
Gonadotropins
3
Folic Acid
3
Uterine Myomectomy
2
Tamoxifen
2
Sugars
2
Progestins
2
Liraglutide
2
High-Energy Shock Waves
2
Flutamide
2
ulipristal acetate
1
testosterone undecanoate
1
methyl N-acetylsibirosaminide
1
hMG-IBSA
1
follitropin alfa
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Thyrotropin
1
Thioctic Acid
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Infertility
×
Caloric Restriction
×
Clear all
NCT01716429
2019-04-18
HER Health
University of South Carolina
Phase NA
Withdrawn